FDA refuse to file BMS/bluebird bio’s CAR-T therapy
The FDA did not request additional clinical or non-clinical data
Read More
Tag: idecabtagene vicleucel
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
- ACD440 granted orphan drug status in the EU
